HBP08
HBP08 is a selective small molecule inhibitor that targets the CXCL12-HMGB1 interaction, binding HMGB1 with a Kd of 0.8 μM. It potently blocks CXCL12-induced cell migration, making it a valuable research tool for studying inflammation, cancer metastasis, and wound healing processes in both cellular and animal models.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1260.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog